NDAINHALATIONGAS
Approved
Jun 2022
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
2/8 — Basic
Drug data last refreshed 21h ago · AI intelligence enriched 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Nitrogen, NF is an inhaled gas product approved by the FDA in June 2022 as a pharmaceutical-grade nitrogen formulation. The product's specific clinical indications and mechanism of action are not publicly detailed in available regulatory records. It represents a specialized inhalation therapy in the NDA portfolio.
Peak
Product is in peak lifecycle stage with low competitive pressure (30%), suggesting stable commercial operations and potential for modest team expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (7)
Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts
Started Nov 2022
60 enrolled
Plan Warts
Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts
Started May 2022
60 enrolled
Cutaneous Warts
Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care
Started Feb 2022
56 enrolled
Nutrition TherapyCritical Illness
Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness
Started Nov 2019
7 enrolled
Critical Illness
The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients
Started Apr 2005
120 enrolled
Gastrointestinal NeoplasmsPostoperative Complications
Worked on Nitrogen, NF at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.